CN105596902A - Traditional Chinese medicine oral liquid for preventing and treating avian influenza and preparation method thereof - Google Patents
Traditional Chinese medicine oral liquid for preventing and treating avian influenza and preparation method thereof Download PDFInfo
- Publication number
- CN105596902A CN105596902A CN201610008179.4A CN201610008179A CN105596902A CN 105596902 A CN105596902 A CN 105596902A CN 201610008179 A CN201610008179 A CN 201610008179A CN 105596902 A CN105596902 A CN 105596902A
- Authority
- CN
- China
- Prior art keywords
- agent
- weight portion
- oral liquid
- fruit
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 239000007788 liquid Substances 0.000 title claims abstract description 32
- 206010064097 avian influenza Diseases 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims description 13
- 208000002979 Influenza in Birds Diseases 0.000 title abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 62
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 37
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 12
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 12
- 244000068988 Glycine max Species 0.000 claims abstract description 5
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 5
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 13
- 244000111489 Gardenia augusta Species 0.000 claims description 12
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 12
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 claims description 12
- 241001480055 Quercus mongolica Species 0.000 claims description 11
- 240000004307 Citrus medica Species 0.000 claims description 10
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 9
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 7
- 238000011321 prophylaxis Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- 241000202807 Glycyrrhiza Species 0.000 claims description 2
- 241000985694 Polypodiopsida Species 0.000 claims description 2
- 241000050051 Chelone glabra Species 0.000 claims 2
- 241000700605 Viruses Species 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 12
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 206010011224 Cough Diseases 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 241000350742 Aglaomorpha fortunei Species 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000009636 Huang Qi Substances 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 235000007164 Oryza sativa Nutrition 0.000 abstract 1
- 206010036790 Productive cough Diseases 0.000 abstract 1
- 240000006394 Sorghum bicolor Species 0.000 abstract 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000010135 fructus aurantii immaturus Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 208000024794 sputum Diseases 0.000 abstract 1
- 210000003802 sputum Anatomy 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 description 10
- 241000712461 unidentified influenza virus Species 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000000840 anti-viral effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 206010022000 influenza Diseases 0.000 description 4
- 206010035664 Pneumonia Diseases 0.000 description 3
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 3
- 229960003805 amantadine Drugs 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229960003752 oseltamivir Drugs 0.000 description 2
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 206010037833 rales Diseases 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000252870 H3N2 subtype Species 0.000 description 1
- 241001473386 H9N2 subtype Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241000134304 Influenza A virus H3N2 Species 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 229940123424 Neuraminidase inhibitor Drugs 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000519989 Scutellaria galericulata Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124344 antianaemic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000008125 glucin Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000016833 positive regulation of signal transduction Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960000888 rimantadine Drugs 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000002911 sialidase inhibitor Substances 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- -1 terpene glycoside Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229960001028 zanamivir Drugs 0.000 description 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides traditional Chinese medicine oral liquid for preventing and treating avian influenza. The oral liquid is composed of an agent A and an agent B, wherein the mass ratio of the agent A to the agent B is 1: (0.17-2.5). The agent A is composed of, by weight, 5-30 parts of fructus gardeniae, 10-50 parts of radix astragali, 10-40 parts of radix glycyrrhizae, 5-25 parts of fructus aurantii immaturus, and 3-10 parts of drynaria roosii. The agent B is composed of, by weight, one or several of plant fruit buds including 10-120 parts of barley malt, 10-120 parts of sorghum shoot, 10-120 parts of rice bud, 10-140 parts of soybean sprout and 10-120 parts of buckwheat sprout. The traditional Chinese medicine oral liquid has the effects of clearing away heat and toxic materials, diminishing inflammation, easing pain, relieving cough, reducing sputum, soothing the nerves, tonifying qi, resisting bacteria and viruses, enhancing immunity of the organism and the like, and can prevent and treat avian influenza well. By means of elaborate and reasonable compatibility, mutual combination can be achieved to enhance the medicine effect; the traditional Chinese medicine oral liquid for preventing and treating avian influenza has the advantages that the preparing technology is simple, the oral liquid can be absorbed by the organism easily, the material range is wide, cost is low, the cure rate is high, no medicine residue is caused, and no toxic or side effect is achieved.
Description
Technical field
The invention belongs to Chinese medicine preparation technical field, relate in particular to a kind of traditional Chinese medicine oral liquid of prophylactic treatment bird fluAnd preparation method thereof.
Background technology
Bird flu (BirdFlu or AvianInfluenza) is the abbreviation of Bird Flu, and it is a kind ofThe communicable disease being caused by a kind of hypotype (also claiming avian influenza virus) of influenza A virus, by international epizootic diseaseOffice is decided to be category A infectious disease, claims again fowl plague or European checken pest. Also can infect the mankind and cause morbidity, become fowlInfluenza infection or avian flu, the metainfective symptom main manifestations of people is high heat, cough, runny nose, myalgiaDeng, most with serious pneumonia, the multiple organ failures such as the severe patient heart, kidney cause death.
Anti-influenza virus medicament is mainly M2 inhibitors of ion channels (amantadine and Rimantadine) or disease at presentPoison neuraminidase inhibitor (Oseltamivir and zanamivir), but all due to its inherent toxicity and prolonged applicationDrug resistance and limited its clinical practice. Find according to up-to-date antiviral study on monitoring, be active in Asia, Australia is largeThe amantadine resistance to the action of a drug influenza virus A type H3N2 strain in Leah, North America and Europe significantly increases, and people is pathogenicThe avian influenza virus of H5N1 avian influenza virus and other hypotypes is also to amantadine resistance. And for neuraminic acid, also there is recently seasonal current Influenza Virus Oseltamivir persister, or even do not had in enzyme inhibitor class medicineIn the patient of medication. Therefore find new anti-influenza virus medicament extremely urgent.
China's traditional Chinese medicine has the advantages such as medicine source is extensive, and toxic and side effect is little, low price, therefore utilizes Chinese medicinePrevention and treatment bird flu a kind of good method of can yet be regarded as. The general principle of Traditional Chinese Medicine Anti influenza virus is " eliminating evil "With " righting ". From modern pharmacology angle analysis, the antiviral approach of Chinese medicine mainly comprises direct inhibition virusWith indirect inhibition virus, directly suppressing virus is that medicine directly acts on virus, the suction of blocking virus reproductive processAttached, penetrate, copy, a certain link in maturation, kill virus or suppress virus replication then, thus reachAntiviral object, indirectly suppresses virus and is medicine by improving the immunologic function of body, by promotion bodySpecificity and non-specific immune function and reach and suppress viral object, besides by inducing, promote to induceThe effect of interferon (IFN) etc. reaches antiviral object.
Summary of the invention
In order to solve the existing problem of existing Anti-avian influenza virus drugs, the invention provides a kind of pre-controlTreat the pure traditional Chinese medicine oral liquid of human avian influenza, by the humidification of mutually promoting between plurality of Chinese, to prevention andQuality bird flu has remarkable efficacy.
The technical scheme that technical solution problem of the present invention adopts is:
A agent and B that a traditional Chinese medicine oral liquid for prophylactic treatment bird flu is 1:0.17-2.5 by mass ratioAgent composition, described A agent is water decoction, is made up of the component of following weight portion: 5-30 weight portion cape jasmine, 10-50The weight portion root of large-flowered skullcap, 10-40 weight portion Radix Glycyrrhizae, the 5-25 weight portion dried immature fruit of citron orange and 3-10 weight portion Mongolian oak fern, described BAgent, for squeezing agent, is made up of one or more in the fresh bud of fruit of following weight portion: 10-120 weightPart fructus hordei germinatus, 10-120 weight portion Chinese sorghum bud, 10-120 weight portion Fructus Oryzae Germinatus, the large bean sprouts of 10-140 weight portionWith 10-120 weight portion buckwheat bud.
As preferably, A agent and B agent that described oral liquid is 1:2 by mass ratio form, and described A agent is by followingThe component composition of weight portion: 20 weight portion cape jasmines, the 30 weight portion roots of large-flowered skullcap, 20 weight portion Radix Glycyrrhizaes, 22 weightPart dried immature fruit of citron orange and 8 weight portion Mongolian oak ferns, described B agent is by one or more in the fresh bud of fruit of following weight portionComposition: 60 weight portion fructus hordei germinatus, 80 weight portion Chinese sorghum buds, 90 weight portion Fructus Oryzae Germinatus, the 80 large bean sprouts of weight portionWith 30 weight portion buckwheat buds.
As preferably, the preparation method of the fresh bud of described fruit is: it is its quality that fruit is added to qualityIn 1-3 10-20 DEG C of clear water doubly, soak 6-24 hour, drain away the water, in 15-30% humidity and 20-25 DEG CLower placement was germinateed after 1-3 days, germinates and obtain the fresh bud of fruit after 1-3 days, and described fruit is largeWheat, Chinese sorghum, paddy, soybean or buckwheat.
Cape jasmine: there is the effects such as the liver of protecting, cholagogic, step-down, calmness, hemostasis, detumescence. Cape jasmine in Chinese medicine cape jasmineSub-glycosides, can antagonism influenza A virus H3N2 infection cell center transcription factor NF-KB in the cell of mediationThe activation of signal transduction pathway, and can suppress its downstream target gene TNF-a and interleukin-6 (IL-6) mRNAHigh level expression, thereby performance viral infection resisting function.
The root of large-flowered skullcap: hardship, cold. Return lung, courage, spleen, stomach, large intestine, small intestinl channel. The root of large-flowered skullcap is that labiate is with rootBe used as medicine. Have heat-clearing and damp-drying drug, cool blood is antiabortive, detoxicating functions. Curing mainly warm heat disease, the infection of the upper respiratory tract, lung heat coughsCough, the disease such as the swollen furuncle sore of jaundice with damp-heat pathogen, pneumonia, dysentery, hemoptysis, hot eyes, fetal irritability, hypertension, carbuncle.The clinical practice of the root of large-flowered skullcap is antibacterial not worse than the coptis, and does not develop immunity to drugs. The total cyclenes of Scullcap total-flavonoid and cape jasmineEther terpene glycoside composition has obvious antiviral effect, and its mechanism of action may be to suppress virus in intracellular increasingGrow and direct killing action to virus.
Radix Glycyrrhizae: taste is sweet, property is flat, nontoxic. There are anti-inflammatory, antiviral and protecting liver and detoxication and enhancing immunologic function etc.Effect. Radix Glycyrrhizae crude extract and mono-ammonium glycyrrhizinate all can significantly suppress H9N2 subtype influenza virus mouse lung adapted strainThe mouse pneumonia sudden change causing, Radix Glycyrrhizae crude extract can obviously extend the life span of influenza infection mouse. SweetGrass glucin infected by influenza has inhibitory action. Licorice polysaccharide has humidification to mouse immunity of organism.
The dried immature fruit of citron orange: hardship, pungent, cold. Return spleen, stomach, liver, the heart channel of Hang-Shaoyin. Cure mainly in stagnant and stop; The full distending pain of ruffian; StoolConstipated; After rushing down dysentery, weigh; Accumulation of pathogens in chest; Gastroptosis; The prolapse of uterus; Prolapse of the anus. Be recovered with the cape jasmine coupling cold serious disease that can cure the woundThe multiple person of rear labor.
Mongolian oak fern: bitter, temperature is nontoxic. To the marrow, use with mend connect wound broken the most refreshing. Treat the long-pending pain of wind blood, broken bloodMeritorious, hemostasis is effect also. That uses with antianaemics is especially good, and its function really has inconceivable wonderful; With kidney-reinforcing drug with it,Can permanent tooth; With lose blood medicinal it, can fill out key, the exclusive outstanding service of the synthetism of incessantly dispeling the wind also. In addition, Mongolian oak fern rootStem is starch-containing, glucose and naringin etc.
Fructus hordei germinatus: taste is sweet, property is flat. Return spleen, stomach warp. Promote qi circulation digestion promoting, spleen benefiting and stimulating the appetite, moves back newborn dissipate-swelling. Fructus Hordei GerminatusAmylase-containing, conversion carbohydrase, protein, protease, Cobastab, lecithin, maltose, grapeThe compositions such as sugar.
Large bean sprouts: taste is sweet, property is flat. Energy invigorating spleen to remove dampness, beneficial blood qi-restoratives, removing toxic substances. For deficiency of the spleen causing weakness of QI, become thinFood, or anaemia less, malnutrition; Arthritis with fixed pain caused by dampness contraction, or oedema, difficult urination; Verruca vulgaris etc. In large bean sproutsContain a large amount of enzymes, especially contain glucose glycosidase.
The present invention has passed through a kind of preparation method of traditional Chinese medicine oral liquid of prophylactic treatment bird flu simultaneously, comprises as followsStep:
(1) take the each component of A agent claimed in claim 1, mix and pulverize;
(2) mixture step (1) Suo Shu is put into container, add quality be its quality 6-10 doubly10-20 DEG C of clear water, soaks 15-60 minute,, after 60-120 minute, obtains after filtering in 90-100 DEG C of decoctionFiltrate, then concentrate to obtain A agent, for subsequent use;
(3) the fresh bud of one or more fruits claimed in claim 1 is mixed, add clear water to pressSqueeze into juice, filter, filtrate is B agent;
(4) take the step that mass ratio is 1:0.17-2.5 (2) gained A agent and step (3) gained BAgent, mixes latter standing 0-15 minute and obtains described traditional Chinese medicine oral liquid.
As preferably, described in step (3), the preparation method of the fresh bud of fruit is: fruit is addedQuality is in its quality 1-3 10-20 DEG C of clear water doubly, soaks 6-24 hour, drains away the water, in 15-30%At humidity and 20-25 DEG C, place after 1-3 days and germinate, obtain the fresh bud of fruit, described fruit be barley,Chinese sorghum, paddy, soybean or buckwheat.
As preferably, clear water quality described in step (3) be the fresh bud quality of fruit 0-2 doubly. Due toIn the fresh bud of fruit, itself just contain compared with high-moisture, therefore, in the time of the real fresh bud large usage quantity of plant fresh fruit, needAdd clear water; In the time that the real fresh bud consumption of plant fresh fruit is less, do not need to add clear water.
Beneficial effect of the present invention is:
1, traditional Chinese medicine oral liquid of the present invention by plurality of Chinese component and the fresh bud of fruit mutually promote andSynergy, directly suppresses avian influenza virus in cell internal breeding, and kill virus, increases exempting from of body simultaneouslyEpidemic disease power, promotes the specificity of body and non-specific immune function and reaches the object that suppresses viral.
2, traditional Chinese medicine oral liquid medicine of the present invention source is extensive, and toxic and side effect is little, and drug resistance is low, low price.
3, the preparation method of traditional Chinese medicine oral liquid medicine of the present invention is simple, is applicable to suitability for industrialized production.
Detailed description of the invention
Further explain the present invention below in conjunction with embodiment, but that embodiment does not do the present invention is any type ofLimit.
Embodiment 1
(1) take cape jasmine 5g, root of large-flowered skullcap 50g, Radix Glycyrrhizae 10g, dried immature fruit of citron orange 25g, Mongolian oak fern 10g, mix alsoPulverize;
(2) mixture step (1) Suo Shu is put into container, add 10 DEG C of clear water of 600g, soak15 minutes, decoct after 60 minutes in 100 DEG C, after filtering filtrate, more concentratedly to obtain A agent, for subsequent use;
(3) fructus hordei germinatus 60g and large bean sprouts 80g are mixed, add 50g clear water to squeeze into juice, filter,Filtrate is B agent;
(4) take 60g (2) gained A agent and 60g step (3) gained B agent, after mixing and get final productDescribed traditional Chinese medicine oral liquid.
Embodiment 2
(1) take cape jasmine 30g, root of large-flowered skullcap 10g, Radix Glycyrrhizae 40g, dried immature fruit of citron orange 12g, Mongolian oak fern 8g, mix alsoPulverize;
(2) mixture step (1) Suo Shu is put into container, add 15 DEG C of clear water of 800g, soak30 minutes, decoct after 100 minutes in 90 DEG C, after filtering filtrate, more concentratedly to obtain A agent, for subsequent use;
(3) 10g fructus hordei germinatus, 10g Chinese sorghum bud, 10g Fructus Oryzae Germinatus, the large bean sprouts of 10g and 10g buckwheat bud is mixedClose evenly, add 100g clear water to squeeze into juice, filter, filtrate is B agent;
(4) take 60g (2) gained A agent and 10g step (3) gained B agent, mix rear leaving standstillWithin 10 minutes, obtain described traditional Chinese medicine oral liquid.
Embodiment 3
(1) take cape jasmine 20g, root of large-flowered skullcap 30g, Radix Glycyrrhizae 20g, dried immature fruit of citron orange 22g, Mongolian oak fern 8g, mix alsoPulverize;
(2) mixture step (1) Suo Shu is put into container, add 20 DEG C of clear water of 1000g, soakSteep 60 minutes, decoct after 120 minutes in 100 DEG C, after filtering filtrate, more concentratedly to obtain A agent, for subsequent use;
(3) 80g Chinese sorghum bud, 90g Fructus Oryzae Germinatus and 30g buckwheat bud are mixed, add 40g clear water to pressSqueeze into juice, filter, filtrate is B agent;
(4) take 100g (2) gained A agent and 200g step (3) gained B agent, mix rear quietPut and within 15 minutes, obtain described traditional Chinese medicine oral liquid.
Embodiment 4
(1) take cape jasmine 30g, root of large-flowered skullcap 50g, Radix Glycyrrhizae 12g, dried immature fruit of citron orange 5g, Mongolian oak fern 3g, mix alsoPulverize;
(2) mixture step (1) Suo Shu is put into container, add 12 DEG C of clear water of 700g, soak40 minutes, decoct after 90 minutes in 95 DEG C, after filtering filtrate, more concentratedly to obtain A agent, for subsequent use;
(3) by 120g fructus hordei germinatus, 120g Chinese sorghum bud, 120g Fructus Oryzae Germinatus, the large bean sprouts of 140g and 120g buckwheatFructus Hordei Germinatus mixes, and does not add clear water and directly squeezes into juice, filters, and filtrate is B agent;
(4) take 100g (2) gained A agent and 250g step (3) gained B agent, mix rear quietPut and within 15 minutes, obtain described traditional Chinese medicine oral liquid.
Comparative example 1A agent group
Take cape jasmine 20g, root of large-flowered skullcap 30g, Radix Glycyrrhizae 20g, dried immature fruit of citron orange 22g, Mongolian oak fern 8g, mix and pulverize,Gained mixture is put into container, add 20 DEG C of clear water of 1000g, soak 60 minutes, decoct in 100 DEG CBoil after 120 minutes, after filtering filtrate, more concentrated to obtain A agent.
Comparative example 2B agent group
80g Chinese sorghum bud, 90g Fructus Oryzae Germinatus and 30g buckwheat bud are mixed, add 40g clear water to squeeze into juice,Filter, filtrate is B agent.
Drug test
Below trying by experiment example further illustrates traditional Chinese medicine oral liquid of the present invention and compares that A agent is used separately, BAgent is used and has more effective effect separately.
Taking 40 mouse that infected bird flu as example, be divided at random 4 groups. Be respectively embodiment 3 oral liquidsGroup, comparative example 1A agent group, comparative example 2B agent group and blank group. Embodiment 3 oral liquid groups are pressed 10ml/kgOral liquid gavage; Comparative example 1A agent group is pressed 10ml/kgA agent gavage; Comparative example 2B agent group is pressed 10ml/kgB agent gavage; Blank group is pressed 10ml/kg physiological saline gavage; Successive administration 7 days, observes each mouse feelingsCondition.
Note: effectively refer to that the state of an illness is clearly better, body temperature is normal, pulmonary rale reduces; Effectively refer to that sb.'s illness took a favorable turn,Body temperature is normal, and pulmonary rale reduces; Invalidly refer to that body temperature is higher than normal value, the state of an illness is without taking a turn for the better or increasing the weight of.
Can be found out by above-mentioned test effect, A agent and B agent meet and traditional Chinese medicine oral liquid (be embodiment 3Oral liquid) to infecting mouse result for the treatment of the best of bird flu, than A agent use separately, B agent makes separately apparatusThere is more effective effect.
Below only enumerate the preferred embodiments of the invention, protection scope of the present invention is not restricted to this, abilityAny change that field technique personnel do within the scope of the claims in the present invention all falls in protection domain of the present invention.
Claims (6)
1. the traditional Chinese medicine oral liquid of a prophylactic treatment bird flu, it is characterized in that, A agent and B agent that described oral liquid is 1:0.17-2.5 by mass ratio form, described A agent is water decoction, formed by following parts by weight of component: 5-30 weight portion cape jasmine, the 10-50 weight portion root of large-flowered skullcap, 10-40 weight portion Radix Glycyrrhizae, the 5-25 weight portion dried immature fruit of citron orange and 3-10 weight portion Mongolian oak fern, described B agent is squeezing agent, formed by one or more in the fresh bud of fruit of following weight portion: 10-120 weight portion fructus hordei germinatus, 10-120 weight portion Chinese sorghum bud, 10-120 weight portion Fructus Oryzae Germinatus, the large bean sprouts of 10-140 weight portion and 10-120 weight portion buckwheat bud.
2. traditional Chinese medicine oral liquid as claimed in claim 1, it is characterized in that, A agent and B agent that described oral liquid is 1:2 by mass ratio form, described A agent is made up of the component of following weight portion: 20 weight portion cape jasmines, the 30 weight portion roots of large-flowered skullcap, 20 weight portion Radix Glycyrrhizaes, the 22 weight portion dried immature fruit of citron oranges and 8 weight portion Mongolian oak ferns, described B agent is made up of one or more in the fresh bud of fruit of following weight portion: 60 weight portion fructus hordei germinatus, 80 weight portion Chinese sorghum buds, 90 weight portion Fructus Oryzae Germinatus, the 80 large bean sprouts of weight portion and 30 weight portion buckwheat buds.
3. traditional Chinese medicine oral liquid as claimed in claim 1 or 2, it is characterized in that, the preparation method of the fresh bud of described fruit is: it is in its quality 1-3 10-20 DEG C of clear water doubly that fruit is added to quality, soak 6-24 hour, drain away the water, place 1-3 days at 15-30% humidity and 20-25 DEG C after, germinate, obtain the fresh bud of fruit, described fruit is barley, Chinese sorghum, paddy, soybean or buckwheat.
4. a method of preparing traditional Chinese medicine oral liquid described in claim 1, is characterized in that, described preparation method comprises the steps:
(1) take the each component of A agent claimed in claim 1, mix and pulverize;
(2) mixture step (1) Suo Shu is put into container, adding quality is its quality 6-10 10-20 DEG C of clear water doubly, soaks 15-60 minute, decoct after 60-120 minute in 90-100 DEG C, after filtering filtrate, more concentratedly to obtain A agent, for subsequent use;
(3) the fresh bud of one or more fruits claimed in claim 1 is mixed, add clear water to squeeze into juice, filter, filtrate is B agent;
(4) take the step that mass ratio is 1:0.17-2.5 (2) gained A agent and step (3) gained B agent, mix latter standing 0-15 minute and obtain described traditional Chinese medicine oral liquid.
5. preparation method as claimed in claim 4, it is characterized in that, described in step (3), the preparation method of the fresh bud of fruit is: it is in its quality 1-3 10-20 DEG C of clear water doubly that fruit is added to quality, soak 6-24 hour, drain away the water, place 1-3 days at 15-30% humidity and 20-25 DEG C after, germinate, obtain the fresh bud of fruit, described fruit is barley, Chinese sorghum, paddy, soybean or buckwheat.
6. preparation method as claimed in claim 4, is characterized in that, clear water quality described in step (3) is 0-2 times of the fresh bud quality of fruit.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610008179.4A CN105596902B (en) | 2016-01-05 | 2016-01-05 | Traditional Chinese medicine oral liquid for treating avian influenza and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610008179.4A CN105596902B (en) | 2016-01-05 | 2016-01-05 | Traditional Chinese medicine oral liquid for treating avian influenza and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105596902A true CN105596902A (en) | 2016-05-25 |
CN105596902B CN105596902B (en) | 2020-10-30 |
Family
ID=55977619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610008179.4A Active CN105596902B (en) | 2016-01-05 | 2016-01-05 | Traditional Chinese medicine oral liquid for treating avian influenza and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105596902B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117064934A (en) * | 2023-08-25 | 2023-11-17 | 浙江工业大学 | Traditional Chinese medicine composition for treating hypertension |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101658247A (en) * | 2009-08-26 | 2010-03-03 | 王直军 | Chinese medicinal feed additive for preventing and treating common diseases of chickens |
-
2016
- 2016-01-05 CN CN201610008179.4A patent/CN105596902B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101658247A (en) * | 2009-08-26 | 2010-03-03 | 王直军 | Chinese medicinal feed additive for preventing and treating common diseases of chickens |
Non-Patent Citations (2)
Title |
---|
李学如等: "《发酵工艺原理与技术》", 31 August 2014, 华中科技大学出版社 * |
邓多: "《这样预防最有效:传染病防治手册》", 31 May 2009, 中国画报出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117064934A (en) * | 2023-08-25 | 2023-11-17 | 浙江工业大学 | Traditional Chinese medicine composition for treating hypertension |
Also Published As
Publication number | Publication date |
---|---|
CN105596902B (en) | 2020-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813034B (en) | Production process and formula of herbal tea beverage | |
WO2022062716A1 (en) | Composition having function of nourishing yin and tonifying kidney, and preparation method therefor and use thereof | |
CN109601993A (en) | One kind is tonified Qi of the kidney nourishing blood and tranquilization nourishing-paste and its preparation process | |
CN112675278A (en) | Composition for moistening lung to arrest cough and inhibiting lung inflammatory reaction and preparation method and application thereof | |
CN111568952A (en) | Concentrated Shuanghuanglian oral liquid preparation for production and preparation method thereof | |
CN105596902A (en) | Traditional Chinese medicine oral liquid for preventing and treating avian influenza and preparation method thereof | |
CN101085962A (en) | Wine of bamboo and cogongrass | |
CN105288273A (en) | Formula for treating nephrotic syndrome and preparation method | |
CN109810824A (en) | A kind of dandelion wheat yellow wine yeast and preparation process | |
CN104146241A (en) | Health composition capable of benefiting bodies and relaxing bowels and preparation method of health composition | |
CN103977112B (en) | A kind of Chinese medicine treating alcoholic liver | |
CN101829219B (en) | Periplaneta Americana pharmaceutical composition for treating ulcerative colitis and preparation method thereof | |
US6884442B2 (en) | Anti-inflammatory agent and foods and drinks containing the same | |
CN102631628B (en) | Method for preparing traditional Chinese medicine (TCM) for treating blood stasis type colitis | |
CN102100842A (en) | Traditional Chinese medicine preparation used for treating diaphragmatic spasm | |
CN102552801A (en) | Medicament for treating tumors | |
CN102652824A (en) | Traditional Chinese medicine composition for treating acute enteritis | |
CN102000254A (en) | Traditional Chinese medicine preparation for treating phrenospasm | |
CN106074824A (en) | Enhancing immunity and the compositions of prophylactic treatment influenza, preparation technology and purposes | |
CN105125782A (en) | Drug for treating hemorrhoids | |
CN105380981A (en) | Stomach nourishing health care product preparation | |
CN104147343A (en) | Traditional Chinese medicine composition for treating infantile malnutrition | |
CN104606638A (en) | Medicine for treating damp-heat type acute eczema and preparation method thereof | |
CN105031223A (en) | Chinese and western medicine compound preparation for treating eczema of external ear | |
CN104587035A (en) | Medicine composition for treating oral ulcer and preparation method for medicine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |